Search Results - "Burmester GR"

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Authors: Farouh ME Kirschner H Harrington RA et al.

Source: Lancet. 8/21/2004, Vol. 364 Issue 9435, p675-684. 10p.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

Authors: Schnitzer TJ Burmester GR Mysler E et al.

Source: Lancet. 8/21/2004, Vol. 364 Issue 9435, p665-674. 10p.

Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis.

Authors: Eisfeld, H Glimm, AM Burmester, GR et al.

Source: Scandinavian Journal of Rheumatology. Jul2021, Vol. 50 Issue 4, p299-306. 8p.

Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report.

Authors: Aringer, M Burkhardt, H Burmester, GR et al.

Source: Lupus. Apr2012, Vol. 21 Issue 4, p386-401. 16p.

RA in 2011: Advances in diagnosis, treatment and definition of remission.

Authors: Burmester GR Burmester, Gerd R

Source: Nature Reviews Rheumatology. Feb2012, Vol. 8 Issue 2, p65-66. 2p.

Shwartzman phenomenon in a patient with active systemic lupus erythematosus preceding fatal disseminated intravascular coagulation.

Authors: Riemekasten, G Ziemer, S Häupl, T et al.

Source: Lupus. 2002, Vol. 11 Issue 4, p204-207. 4p.

Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study.

Authors: Emery, P Bingham, C Burmester, GR et al.

Source: Value in Health. Nov2015, Vol. 18 Issue 7, pA710-A710. 1p.

CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.

Authors: Kolar P Knieke K Hegel JK et al.

Source: Arthritis & Rheumatism. Jan2009, Vol. 60 Issue 1, p123-132. 10p.

Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making [corrected] [published erratum appears in ARTHRITIS RHEUM 2008 Oct;58(10):3278].

Authors: van Der Helm-van Mil AH Detert J le Cessie S et al.

Source: Arthritis & Rheumatism. Aug2008, Vol. 58 Issue 8, p2241-2247. 7p.

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95.

Authors: Jacobi AM Reiter K Mackay M et al.

Source: Arthritis & Rheumatism. Jun2008, Vol. 58 Issue 6, p1762-1773. 12p.

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Authors: Biesen R Demir C Barkhudarova F et al.

Source: Arthritis & Rheumatism. Apr2008, Vol. 58 Issue 4, p1136-1145. 10p.

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)

Authors: Antoni CE Kavanaugh A Kirkham B et al.

Source: Arthritis & Rheumatism. Apr2005, Vol. 52 Issue 4, p1227-1236. 10p.

B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: comment on the editorial by St. Clair and Tedder.

Authors: Goldenberg DM Stein R Leonard JP et al.

Source: Arthritis & Rheumatism. Jul2006, Vol. 54 Issue 7, p2344-2345. 2p.

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.

Authors: Ostendorf L Zernicke J Klotsche J et al.

Source: Nature communications [Nat Commun] 2026 Feb 03; Vol. 17 (1), pp. 1312. Date of Electronic Publication: 2026 Feb 03.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study.

Authors: Gente K Ditz B Bormann E et al.

Source: Vaccines [Vaccines (Basel)] 2026 Jan 29; Vol. 14 (2). Date of Electronic Publication: 2026 Jan 29.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trial.

Authors: Emery P Weinblatt ME Bykerk VP et al.

Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

Transliterated Title: Moderne Wissensvermittlung in der Rheumatologie.

Authors: Burmester GR Krusche M

Source: Zeitschrift fur Rheumatologie [Z Rheumatol] 2026 Jun; Vol. 85 (5), pp. 343-345. Date of Electronic Publication: 2026 Jun 03.

Publication Type: Editorial

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 0414162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-1250 (Electronic) Linking ISSN: 03401855 NLM ISO Abbreviation: Z Rheumatol Subsets: MEDLINE; In Process

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.

Authors: Smolen JS Edwards CJ Konzett V et al.

Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2026 Jun; Vol. 85 (6), pp. 991-1009. Date of Electronic Publication: 2026 Mar 13.

Publication Type: Consensus Statement; Journal Article

Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

Differential diagnosis between psoriatic arthritis and hand osteoarthritis using indocyanine green-based fluorescence optical imaging.

Authors: Drude B Maugesten Ø Werner SG et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2025 Aug 15; Vol. 12, pp. 1581265. Date of Electronic Publication: 2025 Aug 15 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Associations between childhood trauma, depression, anxiety disorders and early arthritis presence.

Authors: Konjikusic A Ohrndorf S Braun T et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2025 Aug 05; Vol. 12, pp. 1582075. Date of Electronic Publication: 2025 Aug 05 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE